Developer docs
API playgroundTry for free, no card

Search company profiles

Together Pharma

Full company profile

uuid003w7i4

Namestring
Together Pharma
Company typeenum
Private
Founded yearint
1991
Descriptiontext

Together Pharma is an Israeli medical cannabis company headquartered in Ramat Gan, Israel, founded in 1991 and publicly listed on the Tel Aviv Stock Exchange under the ticker TGTR. The company operates with 101-250 employees and is positioned within the regulated medical cannabis sector, focused on the cultivation, production, and distribution of cannabis-based therapeutic products. Its public-market status and three-decade operating history predate the modern wave of cannabis legalization, suggesting incumbency in navigating pharmaceutical-grade regulatory frameworks.

The company's reported financials indicate a multi-year operational turnaround: revenue scaled substantially from 2021 through 2025, while gross profit, EBITDA, and operating income moved from deeply negative in 2021-2022 to strongly positive by 2024-2025. Net income reached positive territory in the most recent reporting period after several years of losses, signaling an inflection from cash-burning growth to profitable scaling. The combination of revenue acceleration and margin recovery suggests successful commercialization of higher-value product offerings and improved operational efficiency within the regulated production environment.

Nissim Bracha serves as Partner and CEO, indicating a founder-aligned ownership and management structure. The company has accessed capital markets, including a 2019 funding round led by Hachshara Insurance Company. Together Pharma's go-to-market motion, specific product portfolio, customer segments, geographic reach beyond Israel, and AI/technology capabilities were not disclosed in the available source material, representing meaningful gaps for detailed strategic assessment.

Short descriptiontext

Together Pharma is an Israeli medical cannabis company that cultivates, produces, and distributes regulated therapeutic cannabis products. Founded in 1991 and publicly listed on the Tel Aviv Stock Exchange (TLV:TGTR), the company serves medical cannabis markets with 101-250 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAshkelon, Israel
HQ citystring
Ashkelon
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
medical cannabis, cannabis cultivation, cannabis distribution, pharmaceutical cannabis, cannabis products
Industry2 codes
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Medical Cannabis
Social media profiles1 record
Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Together Pharma is an Israeli medical cannabis company that cultivates, produces, and distributes medical-grade cannabis products. The company operates as a for-profit, publicly-listed entity (TLV:TGTR) serving patients through regulated channels, primarily within Israel's medical cannabis framework.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product information available from the source data.

Product and service1 record
1Medical Cannabis Products
CategoryMedical Cannabis
Description

Medical-grade cannabis products cultivated, produced, and distributed by Together Pharma for patients within Israel's regulated medical cannabis framework.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Canadian licensed producer with extensive European medical cannabis distribution. Comparable to Together Pharma as a GMP-certified medical cannabis supplier targeting EU pharmacy channels.

TypeBroad incumbent
Description

Multi-state/multi-country cannabis operator with dispensary and cultivation operations. Relevant as a broad incumbent competing in adjacent medical cannabis markets.

TypeDirect peer
Description

Canadian medical cannabis producer with European distribution strategy. Comparable in scale, business model (cultivation-to-pharmacy), and regulatory profile.

TypeBroad incumbent
Description

Large multi-jurisdiction cannabis operator with established German medical cannabis business. Relevant peer given overlap in medical channel distribution and product portfolio breadth.

5Wayland Group (ICC International Cannabis Corp.)
TypeEmerging player
Description

Cannabis producer with European distribution ambitions. Comparable as a publicly listed medical cannabis operator pursuing international growth.

TypeEmerging player
Description

Canadian cannabis producer with selective European supply presence. Comparable as a mid-scale medical cannabis cultivator pursuing cross-border distribution.

TypeBroad incumbent
Description

Diversified cannabis company with international medical exposure. Relevant as a broader incumbent operating in adjacent medical cannabis geographies.

TypeDirect peer
Description

Israeli medical cannabis producer and GMP-certified cultivator operating in the same domestic regulatory framework as Together Pharma.

TypeDirect peer
Description

Israeli-founded medical cannabis company (also traded publicly) with European-focused distribution. Among the closest direct comparables to Together Pharma given shared Israeli origin and European medical channel strategy.

10Tilray Brands
TypeDirect peer
Description

Global medical and recreational cannabis cultivator/producer with significant European medical footprint. Tilray is a direct competitor for European medical cannabis supply and serves comparable pharmacy and dispensary channels.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Together Pharma

Medical Cannabistogether-pharma.com

Together Pharma is an Israeli medical cannabis company that cultivates, produces, and distributes regulated therapeutic cannabis products. Founded in 1991 and publicly listed on the Tel Aviv Stock Exchange (TLV:TGTR), the company serves medical cannabis markets with 101-250 employees.

What Together Pharma does

Together Pharma is an Israeli medical cannabis company headquartered in Ramat Gan, Israel, founded in 1991 and publicly listed on the Tel Aviv Stock Exchange under the ticker TGTR. The company operates with 101-250 employees and is positioned within the regulated medical cannabis sector, focused on the cultivation, production, and distribution of cannabis-based therapeutic products. Its public-market status and three-decade operating history predate the modern wave of cannabis legalization, suggesting incumbency in navigating pharmaceutical-grade regulatory frameworks.

The company's reported financials indicate a multi-year operational turnaround: revenue scaled substantially from 2021 through 2025, while gross profit, EBITDA, and operating income moved from deeply negative in 2021-2022 to strongly positive by 2024-2025. Net income reached positive territory in the most recent reporting period after several years of losses, signaling an inflection from cash-burning growth to profitable scaling. The combination of revenue acceleration and margin recovery suggests successful commercialization of higher-value product offerings and improved operational efficiency within the regulated production environment.

Nissim Bracha serves as Partner and CEO, indicating a founder-aligned ownership and management structure. The company has accessed capital markets, including a 2019 funding round led by Hachshara Insurance Company. Together Pharma's go-to-market motion, specific product portfolio, customer segments, geographic reach beyond Israel, and AI/technology capabilities were not disclosed in the available source material, representing meaningful gaps for detailed strategic assessment.

Together Pharma firmographics

Firmographics
Name
Together Pharma
Website
https://together-pharma.com
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
11–50 employees
Short description
Together Pharma is an Israeli medical cannabis company that cultivates, produces, and distributes regulated therapeutic cannabis products. Founded in 1991 and publicly listed on the Tel Aviv Stock Exchange (TLV:TGTR), the company serves medical cannabis markets with 101-250 employees.
Ownership category
akta.pro rank

Together Pharma industry classification

Industry
Product category
Medical Cannabis
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAI
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Medical cannabis
  • Cannabis cultivation
  • Cannabis distribution
  • Pharmaceutical cannabis
  • Cannabis products

Where Together Pharma is headquartered

Location

Headquarters

HQ city
Ashkelon
HQ country
Israel
HQ region
Middle East

Markets served

Together Pharma business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Together Pharma product offering

Product offering

Core offering

Together Pharma is an Israeli medical cannabis company that cultivates, produces, and distributes medical-grade cannabis products. The company operates as a for-profit, publicly-listed entity (TLV:TGTR) serving patients through regulated channels, primarily within Israel's medical cannabis framework.

Product overview

No product information available from the source data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Cannabis Products Medical-grade cannabis products cultivated, produced, and distributed by Together Pharma for patients within Israel's regulated medical cannabis framework.

Companies that use Together Pharma

Customer profile

Ideal customer profiles1 record

Together Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Together Pharma partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights3 records

Together Pharma competitors and assessment

Company assessment

Direct peers

  • Aurora Cannabis: Canadian licensed producer with extensive European medical cannabis distribution. Comparable to Together Pharma as a GMP-certified medical cannabis supplier targeting EU pharmacy channels.
  • OrganiGram Holdings: Canadian medical cannabis producer with European distribution strategy. Comparable in scale, business model (cultivation-to-pharmacy), and regulatory profile.
  • Canndoc (InterCure subsidiary): Israeli medical cannabis producer and GMP-certified cultivator operating in the same domestic regulatory framework as Together Pharma.
  • IM Cannabis (InterCure): Israeli-founded medical cannabis company (also traded publicly) with European-focused distribution. Among the closest direct comparables to Together Pharma given shared Israeli origin and European medical channel strategy.
  • Tilray Brands: Global medical and recreational cannabis cultivator/producer with significant European medical footprint. Tilray is a direct competitor for European medical cannabis supply and serves comparable pharmacy and dispensary channels.

Broad incumbents

  • Curaleaf Holdings: Multi-state/multi-country cannabis operator with dispensary and cultivation operations. Relevant as a broad incumbent competing in adjacent medical cannabis markets.
  • Canopy Growth: Large multi-jurisdiction cannabis operator with established German medical cannabis business. Relevant peer given overlap in medical channel distribution and product portfolio breadth.
  • Cronos Group: Diversified cannabis company with international medical exposure. Relevant as a broader incumbent operating in adjacent medical cannabis geographies.

Emerging players

  • Wayland Group (ICC International Cannabis Corp.): Cannabis producer with European distribution ambitions. Comparable as a publicly listed medical cannabis operator pursuing international growth.
  • Sundial Growers: Canadian cannabis producer with selective European supply presence. Comparable as a mid-scale medical cannabis cultivator pursuing cross-border distribution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Together Pharma social profiles

Digital presence

Together Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Together Pharma leadership team

Management profile

Number of profiles

Profiles1 record

Together Pharma funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Together Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Together Pharma

What does Together Pharma do?

Together Pharma is an Israeli medical cannabis company that cultivates, produces, and distributes medical-grade cannabis products. The company operates as a for-profit, publicly-listed entity (TLV:TGTR) serving patients through regulated channels, primarily within Israel's medical cannabis framework.

When was Together Pharma founded?

Together Pharma was founded in 1991. It employs 11 to 50 people.

Where is Together Pharma based?

Together Pharma is headquartered in Ashkelon, Israel, in the Middle East region.

Who are Together Pharma's main competitors?

Direct peers on record are Aurora Cannabis, OrganiGram Holdings, Canndoc (InterCure subsidiary), IM Cannabis (InterCure) and Tilray Brands. Broad incumbents are Curaleaf Holdings, Canopy Growth and Cronos Group. Emerging players are Wayland Group (ICC International Cannabis Corp.) and Sundial Growers.

Does Together Pharma have an API?

No public API is recorded for Together Pharma.

What industry is Together Pharma in?

Together Pharma's product category is Medical Cannabis. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries, with a secondary code of CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCantourage, Cannabis House and Together Pharma partner to increase availability of medical cannabis in PolandCantourage Group SE, Cannabis House, and Together Pharma have formed a partnership to bring Ugandan medical cannabis to Poland for the first time, making Together Pharma's Glueberry OG® cultivar available to patients through selected pharmacies starting December 2022. Poland marks the third European market for the product after Germany and the UK, with a three-year supply agreement covering importation of over 500 kg of finished dried cannabis flowers. The partnership addresses Poland's medical cannabis demand, which has quadrupled over the past three years, with additional products from Cantourage's existing portfolio expected to follow.PR NewswireCantourage, Cannabis House i Together Pharma współpracują w celu zwiększenia dostępności medycznej marihuany w PolsceCantourage, Cannabis House and Together Pharma announced a collaboration to make medical marijuana from Uganda available in Poland for the first time, starting the first week of December 2022. The supply agreement covers import of over 500 kg of finished cannabis flower over three years, distributed through selected pharmacies across the country. Poland becomes the third European market for the product after the United Kingdom and Germany, with additional products planned for introduction in coming months.PR NewswireCantourage, Cannabis House und Together Pharma kooperieren und erweitern so das Angebot von medizinischem Cannabis in PolenCantourage Group SE, Cannabis House, and Together Pharma have partnered to introduce Ugandan medical cannabis to the Polish market, with the Glueberry OG® cultivar becoming available to patients through the Cannabis House initiative starting in early December via pharmacies nationwide. Under a three-year supply agreement, more than 500 kg of dried cannabis flowers will be imported to Poland, marking the product's entry as the third European market after Germany and the United Kingdom. The Polish medical cannabis market has quadrupled over the past three years, with demand currently at an all-time high.GlobeNewswireTel Aviv Listed Together Pharma’s Subsidiary Globus Pharma Ltd and BYND Cannasoft Enterprises’ Subsidiary Sign First Commercial Agreement for Medical Cannabis ProductsBYND Cannasoft's Israeli subsidiary signed an agreement with Globus Pharma, a Together Pharma subsidiary, for cultivation, production, and distribution of medical cannabis products. The products will be marketed exclusively in Israel, with full licensing pending from Israel's Medical Cannabis Unit. The company expects significant revenue before manufacturing and distribution costs.PR NewswireCantourage importe le premier cannabis thérapeutique ougandais en Allemagne grâce à un partenariat avec l'entreprise israélienne Together PharmaEuropean medical cannabis leader Cantourage and Israeli producer Together Pharma (TASE: TGTR) have formed a partnership to import the first Ugandan-grown medical cannabis products into Germany, beginning with dried flower cultivars Glueberry OG® and Power Plant. Together Pharma is the only medical cannabis cultivator operating in Uganda, with a greenhouse facility spanning approximately 30,000 m² and an annual production capacity exceeding 15 tonnes. The products will be distributed to pharmacies across Germany in the coming weeks, marking the first African-cultivated medical cannabis available through Cantourage's rapid-access platform, which currently holds contracts with 18 cultivators across 13 countries.PR NewswireCantourage brings first Ugandan medical cannabis to Germany through partnership with Israel's Together PharmaEuropean medical cannabis company Cantourage and Israeli producer Together Pharma have formed a partnership to bring the first Ugandan medical cannabis products to Germany, with Glueberry OG® and Power Plant cultivars now available to pharmacies and patients. Together Pharma operates approximately 30,000 sqm of greenhouses in Uganda with a production capacity exceeding 15 tons annually, making it the only cultivator of medical cannabis in Uganda. This partnership marks the first African medical cannabis product to enter the German market through Cantourage's Fast Track Access Platform, which has signed contracts with 18 cultivators from 13 countries.IFTTTTogether Pharma sells first medical cannabis in GermanyTogether Pharma sold its first 50 kilograms of medical cannabis inflorescences in Germany, cultivated in Uganda. The company plans regular imports to capture market share in Germany's infant market, where 10 tons were consumed in 2020. It is in contact with other strategic customers for future sales.GlobesTogether subsidizes sales for medical cannabis export permitTogether Pharma announced participation in a Ministry of Health pilot project to expedite export permits for medical cannabis. The company will discount products to NIS 100-140 per 10g package and apply for a permit. CEO Nissim Bracha said the company plans immediate exports to Europe and Brazil.GlobesTogether wins medical cannabis export permit from UgandaTogether Pharma received approval from Uganda's National Drug Authority to export medical cannabis to Germany, Malta, and Israel. The company's 7.5-acre farm in Uganda has WHO GACP certification. CEO Nissim Bracha said it is the first African company to export medical cannabis in commercial quantities.GlobesTogether signs NIS 192m deal to grow cannabis for Canna-TechTogether Pharma signed a deal with Canna-Tech worth at least NIS 192.5 million, to cultivate five tons of medical cannabis annually at an Ashkelon farm over five years. The deal includes NIS 5.50 per gram and NIS 10 million in packing services, with a NIS 5 million payment within three days.